Form 8-K OSIRIS THERAPEUTICS, For: May 08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- US stock futures rise after previous session's selloff
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Osiris Therapeutics (OSIR) Tops Q1 EPS by 4c
May 8, 2015 8:03 AM EDTOsiris Therapeutics (NASDAQ: OSIR) reported Q1 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $21 million versus the consensus estimate of $18.4 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
... More